As of 1:36pm ET
| +0.07 / +0.80%|
The 7 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +35.59% increase from the last price of 8.85.
The current consensus among 8 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.